D8 (RBOT)
(Delayed Data from NYSE)
$8.12 USD
-1.27 (-13.53%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $8.07 -0.05 (-0.62%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for Vicarious Surgical Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 98 | 116 | 174 | 1 | -99,999 |
Receivables | 0 | 0 | 0 | 0 | NA |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 0 | 0 | 0 | 0 | NA |
Other Current Assets | 3 | 4 | 5 | 0 | NA |
Total Current Assets | 101 | 120 | 178 | 1 | NA |
Net Property & Equipment | 6 | 7 | 2 | 0 | NA |
Investments & Advances | 0 | 0 | 0 | 345 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 0 | 0 | 0 | 0 | NA |
Deposits & Other Assets | 1 | 1 | 1 | 0 | NA |
Total Assets | 120 | 140 | 182 | 346 | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 1 | 2 | 2 | 0 | NA |
Current Portion Long-Term Debt | 0 | 0 | 1 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | NA |
Accrued Expenses | 5 | 6 | 4 | 0 | NA |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 0 | 0 | 0 | 0 | NA |
Total Current Liabilities | 7 | 8 | 6 | 0 | NA |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 2 | 12 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 0 | 0 | 1 | 0 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | NA |
Other Non-Current Liabilities | 1 | 6 | 90 | 329 | NA |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 22 | 29 | 99 | 341 | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | NA |
Capital Surplus | 231 | 173 | 150 | 5 | NA |
Retained Earnings | -133 | -62 | -67 | 0 | NA |
Other Equity | 0 | 0 | 0 | 0 | NA |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 98 | 111 | 83 | 5 | NA |
Total Liabilities & Shareholder's Equity | 120 | 140 | 182 | 346 | NA |
Total Common Equity | 98 | 111 | 83 | 5 | 0 |
Shares Outstanding | 175.50 | 125.80 | 118.60 | 43.10 | NA |
Book Value Per Share | 0.56 | 0.88 | 0.70 | 0.12 | 0.00 |
Fiscal Year End for Vicarious Surgical Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 84 | 98 | 110 | 83 | 98 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 3 | 3 | 3 | 4 |
Total Current Assets | 87 | 101 | 113 | 85 | 101 |
Net Property & Equipment | 6 | 6 | 6 | 6 | 6 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 105 | 120 | 132 | 105 | 121 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 2 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 5 | 5 | 5 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 5 | 7 | 8 | 7 | 7 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 3 | 2 | 7 | 12 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 21 | 22 | 24 | 29 | 33 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 234 | 231 | 228 | 180 | 176 |
Retained Earnings | -150 | -133 | -120 | -104 | -89 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 84 | 98 | 108 | 76 | 88 |
Total Liabilities & Shareholder's Equity | 105 | 120 | 132 | 105 | 121 |
Total Common Equity | 84 | 98 | 108 | 76 | 88 |
Shares Outstanding | 147.20 | 175.50 | 174.80 | 127.30 | 126.90 |
Book Value Per Share | 0.57 | 0.56 | 0.62 | 0.59 | 0.69 |